Overview
Walter Nalesnik is a primary care provider, practicing in Internal Medicine in Lynn, Massachusetts. Dr. Nalesnik has been practicing medicine for over 43 years and is rated as an Advanced provider by MediFind in the treatment of Transient Familial Hyperbilirubinemia. His top areas of expertise are Obesity in Children, Hypothyroidism, Barrett Esophagus, and Urinary Tract Infection in Children.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
St. Joseph Hospital Of Nashua Nh
Mark Ferlan is a primary care provider, practicing in Internal Medicine in Nashua, New Hampshire. Dr. Ferlan is rated as an Advanced provider by MediFind in the treatment of Transient Familial Hyperbilirubinemia. His top areas of expertise are Primary Intestinal Lymphangiectasia, Meige Disease, Lymphedema, and Thyroid Dysgenesis.
Lahey Clinic Inc
Jennifer Rehm is a primary care provider, practicing in Internal Medicine in Burlington, Massachusetts. Dr. Rehm is rated as an Advanced provider by MediFind in the treatment of Transient Familial Hyperbilirubinemia. Her top areas of expertise are Lichen Planus, Bullous Pemphigoid, Hypertension, Familial Hypertension, and Endoscopy.
The General Hospital Corporation
Steven Atlas is a primary care provider, practicing in Internal Medicine in Boston, Massachusetts. Dr. Atlas is rated as an Advanced provider by MediFind in the treatment of Transient Familial Hyperbilirubinemia. His top areas of expertise are Transient Familial Hyperbilirubinemia, Thyroid Dysgenesis, Congenital Hypothyroidism, Colonoscopy, and Endoscopy. Dr. Atlas is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Obesity in ChildrenDr. Nalesnik isDistinguished. Learn about Obesity in Children.
- Advanced
- Adrenal Gland AdenomaDr. Nalesnik isAdvanced. Learn about Adrenal Gland Adenoma.
- Barrett EsophagusDr. Nalesnik isAdvanced. Learn about Barrett Esophagus.
- Cardiac DiverticulumDr. Nalesnik isAdvanced. Learn about Cardiac Diverticulum.
- Chronic CoughDr. Nalesnik isAdvanced. Learn about Chronic Cough.
- Colorectal CancerDr. Nalesnik isAdvanced. Learn about Colorectal Cancer.
- Congenital HypothyroidismDr. Nalesnik isAdvanced. Learn about Congenital Hypothyroidism.
- Experienced
- Acquired AgranulocytosisDr. Nalesnik isExperienced. Learn about Acquired Agranulocytosis.
- Acute CystitisDr. Nalesnik isExperienced. Learn about Acute Cystitis.
- Acute Kidney FailureDr. Nalesnik isExperienced. Learn about Acute Kidney Failure.
- Acute PancreatitisDr. Nalesnik isExperienced. Learn about Acute Pancreatitis.
- Alcoholic CirrhosisDr. Nalesnik isExperienced. Learn about Alcoholic Cirrhosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Nalesnik isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.